Analysis of fatal outcomes of patients with mucopolysaccharidosis type II according to the Russian mucopolysaccharidosis registry

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

HTML

Figures (1-2)

Tables (1-5)

Sum=21

Sep 9, 2025 (publication date) through Jun 16, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Pediatrics

ISSN

2219-2808

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Clin Pediatr. Sep 9, 2025; 14(3): 104689
Published online Sep 9, 2025. doi: 10.5409/wjcp.v14.i3.104689

Full Size Figure Download Figure

Figure 2 The survival of the patients with mucopolysaccharidosis type II depends on the presence of neuronopathic form. NPF: Neuronopathic form.

Citation: Buchinskaya N, Vechkasova A, Vashakmadze N, Namazova-Baranova L, Ivanov D, Zakharova E, Kutsev S, Kostik M. Analysis of fatal outcomes of patients with mucopolysaccharidosis type II according to the Russian mucopolysaccharidosis registry. World J Clin Pediatr 2025; 14(3): 104689
URL: https://www.wjgnet.com/2219-2808/full/v14/i3/104689.htm
DOI: https://dx.doi.org/10.5409/wjcp.v14.i3.104689